V023-5143 Screening compound: N-[(4-fluorophenyl)methyl]-3-{[5-(4-methoxyphenoxy)-2-(4-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzamide

V023-5143 Screening compound: N-[(4-fluorophenyl)methyl]-3-{[5-(4-methoxyphenoxy)-2-(4-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzamide
V023-5143 Screening compound: N-[(4-fluorophenyl)methyl]-3-{[5-(4-methoxyphenoxy)-2-(4-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-5143
N-[(4-fluorophenyl)methyl]-3-{[5-(4-methoxyphenoxy)-2-(4-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-5143

Molecular Formula

C32H27FN4O4 (C32 H27 FN4 O4)

Compound Name

N-[(4-fluorophenyl)methyl]-3-{[5-(4-methoxyphenoxy)-2-(4-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzamide

IUPAC name

N-[(4-fluorophenyl)methyl]-3-{[5-(4-methoxyphenoxy)-2-(4-methylphenyl)-3-oxo-23-dihydropyridazin-4-yl]amino}benzamide

SMILES

Cc(cc1)ccc1N(C1=O)N=CC(Oc(cc2)ccc2OC)=C1Nc1cccc(C(NCc(cc2)ccc2F)=O)c1

InChI

InChI=1S/C32H27FN4O4/c1-21-6-12-26(13-7-21)37-32(39)30(29(20-35-37)41-28-16-14-27(40-2)15-17-28)36-25-5-3-4-23(18-25)31(38)34-19-22-8-10-24(33)11-9-22/h3-18,20,36H,19H2,1-2H3,(H,34,38)

InChI Key

KKXQXRYPVTZZJX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19831922

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

550.59

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.672

Distribution Coefficient, logD

5.642

Water Solubility, LogSw

-5.45

Polar Surface Area

75.274

Acid Dissociation Constant (pKa)

11.18

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.40

V023-5143 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
Targets:
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V023-5143 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-5143?
Check Price and Availability of V023-5143, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-5143 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-5143
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-5143
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-5143 available by request